• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec17
H.C. Wainwright Maintains Buy Rating on AbSci Stock
17:47
Dec12
Needham Maintains Buy Rating on AbSci with Target Price of $7
11:38
Dec4
JonesTrading Analyst Maintains Buy Rating on AbSci
16:07
Absci Corporation Begins Phase 1/2a Trial for Alopecia Antibody ABS-201
13:00
Nov13
Absci released FY2025 Q3 earnings on November 12 After-Market EST, actual revenue USD 0 (forecast USD 1.58 M), actual EPS USD 0 (forecast USD -0.2159)
00:00
Absci released FY2025 9 Months Earnings on November 12 After-Market EST, with actual revenue of USD 2.15 M and EPS of USD -0.6509
00:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 378 K, Net Income -28.71 M, EPS -0.1996

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 593 K, Net Income -30.57 M, EPS -0.2395

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.179 M, Net Income -26.35 M, EPS -0.2116

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LAZR
0.6044
+174.73%
+0.384
NBY
5.300
+79.66%
+2.350
MIMI
0.4795
+75.45%
+0.206
AZI
2.500
+64.47%
+0.980
GDC
5.260
+51.59%
+1.790
SOS
2.200
+47.65%
+0.710
IBO
0.6491
+46.26%
+0.205
FLYT
17.130
+45.42%
+5.350
CRWG
3.950
+45.22%
+1.230
CRWU
7.290
+44.93%
+2.260
View More